| Mucoadhesive beclomethasone microspheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation. | |
| | |
MedLine Citation:
|
PMID: 11943399 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The feasibility of prolonging drug action and/or reducing drug dosage using mucoadhesive beclomethasone dipropionate (BDP) microspheres for powder inhalation was investigated. BDP was spray-dried from ethanol solution or aqueous suspension systems dissolving a mucoadhesive polymer, hydroxypropylcellulose (HPC); this resulted in amorphous and crystalline BDP incorporation in the HPC microspheres (aBDP/HPC and cBDP/HPC; BDP-HPC ratio=1:4), respectively. These microspheres were administered as powder aerosols to healthy or antigen-induced, asthmatic guinea pigs, and BDP's retention in the lung (pharmacokinetics) and inhibitory duration with respect to eosinophil infiltration into the airways (pharmacodynamics) were compared to those for pure crystalline BDP (cBDP; 'control'). Both BDP/HPC microspheres were prepared within a respirable-size range of 2.5-2.9 microm. BDP's aqueous solubility was increased 25 times for aBDP/HPC, compared to crystalline counterpart. Pharmacokinetic profiles for three powders were dissolution-modulated. aBDP/HPC showed rapid BDP absorption from the lung (> or = 95% absorption for 180 min) with a greater metabolite (B17MP) formation, compared to cBDP, primarily due to the increased dissolution of amorphous BDP. In contrast, 86.0% of BDP remained at 180 min following cBDP/HPC administration, demonstrating the prolonged BDP's retention in the lung by virtue of poor dissolution (and/or release) and retarded mucociliary clearance. As a result, while cBDP (1.37 mg/kg) significantly inhibited eosinophil infiltration into the lungs of antigen-sensitized and -challenged guinea pigs for only 1-6 h, cBDP/HPC, despite a much lower drug dosage (0.25 mg/kg), was capable of maintaining such inhibitory effects for 24 h following administration. It appeared therefore that the prolonged lung retention of BDP by the use of the HPC microspheres (cBDP/HPC) was attributed to prolonging its pharmacological duration without requiring increased drug dosage. |
| | |
Authors:
|
Masahiro Sakagami; Wataru Kinoshita; Kiyoyuki Sakon; Jun-ichi Sato; Yuji Makino |
Related Documents
:
|
932619 - Ciliary propulsion of objects in tubes: wall drag on swimming tetrahymena (ciliata) in ... 20864169 - A strategy for precision engineering of nanoparticles of biodegradable copolymers for q... 18819029 - Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine. 15018979 - Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycoli... 6527279 - Ethylene-vinyl acetate copolymer microspheres for controlled release of macromolecules. 18334929 - Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanopa... 10989839 - In vivo studies on nasal preparations of ciprofloxacin hydrochloride. 3013039 - Cloning of pediatric malignancies for drug sensitivity testing in the human tumor cloni... 14747419 - Role of stereoselective assays in bioequivalence studies of racemic drugs: have we reac... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Journal of controlled release : official journal of the Controlled Release Society Volume: 80 ISSN: 0168-3659 ISO Abbreviation: J Control Release Publication Date: 2002 Apr |
Date Detail:
|
Created Date: 2002-04-10 Completed Date: 2002-07-02 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 8607908 Medline TA: J Control Release Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 207-18 Citation Subset: IM |
Affiliation:
|
DDS Research Laboratories, Teijin Ltd., Asahigaoka, Hino, Tokyo 191-8512, Japan. msakagam@vcu.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adhesives
/
administration & dosage,
pharmacokinetics* Administration, Inhalation Animals Anti-Inflammatory Agents / administration & dosage, pharmacokinetics Beclomethasone / administration & dosage, pharmacokinetics* Dose-Response Relationship, Drug Drug Evaluation, Preclinical / methods, statistics & numerical data Guinea Pigs Lung / drug effects, metabolism Male Microspheres Powders |
| Chemical | |
Reg. No./Substance:
|
0/Adhesives; 0/Anti-Inflammatory Agents; 0/Powders; 4419-39-0/Beclomethasone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Physicochemical behavior and cytotoxic effects of p(methacrylic acid-g-ethylene glycol) nanospheres ...
Next Document: Multivalent interactions between biotin-polyrotaxane conjugates and streptavidin as a model of new t...